About
What it is and where it shows up.
Cocoa butter substitute (CBS) is a vegetable fat — derived from palm kernel oil, coconut oil, palm oil stearin, or other plant oils — engineered to mimic the melting profile and texture of cocoa butter. It is used in confectionery coatings, compound chocolates, frostings, and sweet sauces as a cost-effective, tempering-free alternative to cocoa butter.
Safety summary
The regulatory and scientific consensus.
CBS is broadly recognised as safe for the general adult population, with no established ADI and no significant regulatory concern at typical dietary exposures (mean ~5 g/day). Lauric-type CBS (from palm kernel or coconut oil) has a high saturated fat content, and excessive consumption may raise LDL cholesterol in line with general saturated fat guidance; however, human trials show no acute differences in blood glucose, insulin, or triglycerides vs. cocoa butter. No IARC carcinogenicity classification applies; no major jurisdiction has banned CBS.
Regulatory landscape
What food-safety regulators have decided.
| Jurisdiction | Status | Note |
|---|---|---|
| EFSA (European Food Safety Authority) (European Union) | Restricted | EU Directive 2000/36/EC permits use of vegetable fats (including CBS) up to a maximum of 5% of the finished chocolate product in lieu of cocoa butter in chocolate sold within the EU (except in certain countries where standards of identity are stricter). CBS must be disclosed on label.source |
| FSSAI (Food Safety and Standards Authority of India) (India) | Restricted | FSSAI Food Products Standards and Additives Regulations 2011 permit use of CBS/CBR in compound chocolate and confectionery coatings; product must be labelled as 'compound' or 'chocolate-flavoured' coating rather than 'chocolate' when CBS replaces cocoa butter.source |
| FSANZ (Food Standards Australia New Zealand) (Australia) | Approved | Food Standards Australia New Zealand permits CBS in compound coatings and confectionery; products must meet labelling requirements distinguishing compound coatings from standardised chocolate.source |
| FDA (Food and Drug Administration) (United States) | Approved | CBS from palm oil stearin + stearic acid is GRAS (GRN 654) for confections/frostings (10–30%), soft candy coatings (25–40%), and sweet sauces/toppings (5–30%). CBS from palm oil is GRAS under 21 CFR 184.1259 (GMP). CBS from coconut oil/palm kernel oil is approved under 21 CFR 172.861 as a coating material and in lieu of cocoa butter in sweets. |
Who should approach with care
Whose guidance would steer them away.
Heart Disease — Lauric-type CBS (from palm kernel or coconut oil) is high in saturated fatty acids; individuals with existing cardiovascular disease or high LDL cholesterol should limit intake in line with general saturated fat guidance from WHO and national dietary authorities.
Diabetes — CBS is typically found in confectionery products with high sugar loads; people with diabetes should limit consumption of such products, though CBS itself showed no significant effect on blood glucose in controlled trials.
Infants — Confectionery products containing CBS are not appropriate for infants; lauric CBS from palm kernel oil has a fatty acid profile not suited to infant nutrition, and high saturated fat products are generally not recommended for this group.
Children — CBS-containing compound chocolates and confections are high in saturated fat and sugar; dietary guidelines from WHO and national authorities recommend limiting saturated fat and added sugar in children's diets.
— High-fat confectionery containing CBS may be inappropriate for individuals with liver disease due to overall saturated fat and caloric load; patients should follow clinician dietary advice.
Research citations
The sources behind this verdict.
- 1FDA. FDA Food Additive Status List – Cocoa butter substitute from palm oil (GRAS) and from coconut/palm kernel oil (21 CFR 172.861). fda.gov
- 2PubMed. Thermorheological Characterization of Healthier Reduced-Fat Cocoa Butter Formulated by Substitution with a Hydroxypropyl Methylcellulose (HPMC)-Based Oleogel, 2021. ncbi.nlm.nih.gov
- 3PubMed. Analysis of the effect of recent reformulation strategies on the crystallization behaviour of cocoa butter and the structural properties of chocolate, 2021. pmc.ncbi.nlm.nih.gov
- 4PubMed. Effects of Cocoa Butter and Cocoa Butter Equivalent in a Chocolate Confectionery on Human Blood Triglycerides, Glucose and Insulin, 2020. ncbi.nlm.nih.gov
- 5FDA. Agency Response Letter GRAS Notice No. GRN 000654 – Cocoa Butter Substitute (palm oil stearin and stearic acid), 2018. fda.gov
Independently researched5 citations